Exelixis
EXEL
#2017
Rank
NZ$13.39 B
Marketcap
$46.61
Share price
-0.85%
Change (1 day)
29.43%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company